6.
Hollands G, French D, Griffin S, Prevost A, Sutton S, King S
. The impact of communicating genetic risks of disease on risk-reducing health behaviour: systematic review with meta-analysis. BMJ. 2016; 352:i1102.
PMC: 4793156.
DOI: 10.1136/bmj.i1102.
View
7.
Choi J, Jia G, Wen W, Shu X, Zheng W
. Healthy lifestyles, genetic modifiers, and colorectal cancer risk: a prospective cohort study in the UK Biobank. Am J Clin Nutr. 2021; 113(4):810-820.
PMC: 8023827.
DOI: 10.1093/ajcn/nqaa404.
View
8.
Adams L, Richmond J, Corbie-Smith G, Powell W
. Medical Mistrust and Colorectal Cancer Screening Among African Americans. J Community Health. 2017; 42(5):1044-1061.
PMC: 5654700.
DOI: 10.1007/s10900-017-0339-2.
View
9.
Turnbull C, Sud A, Houlston R
. Cancer genetics, precision prevention and a call to action. Nat Genet. 2018; 50(9):1212-1218.
PMC: 6420140.
DOI: 10.1038/s41588-018-0202-0.
View
10.
Burke W, Coughlin S, Lee N, Weed D, Khoury M
. Application of population screening principles to genetic screening for adult-onset conditions. Genet Test. 2002; 5(3):201-11.
DOI: 10.1089/10906570152742245.
View
11.
Emmons K, Colditz G
. Realizing the Potential of Cancer Prevention - The Role of Implementation Science. N Engl J Med. 2017; 376(10):986-990.
PMC: 5473684.
DOI: 10.1056/NEJMsb1609101.
View
12.
Glanz K, Volpicelli K, Kanetsky P, Ming M, Schuchter L, Jepson C
. Melanoma genetic testing, counseling, and adherence to skin cancer prevention and detection behaviors. Cancer Epidemiol Biomarkers Prev. 2013; 22(4):607-14.
PMC: 3617083.
DOI: 10.1158/1055-9965.EPI-12-1174.
View
13.
Meisel S, Side L, Fraser L, Gessler S, Wardle J, Lanceley A
. Population-based, risk-stratified genetic testing for ovarian cancer risk: a focus group study. Public Health Genomics. 2013; 16(4):184-91.
DOI: 10.1159/000352028.
View
14.
Weinberg D, Myers R, Keenan E, Ruth K, Sifri R, Ziring B
. Genetic and environmental risk assessment and colorectal cancer screening in an average-risk population: a randomized trial. Ann Intern Med. 2014; 161(8):537-45.
PMC: 4412019.
DOI: 10.7326/M14-0765.
View
15.
Lacaze P, Tiller J, Winship I
. Healthcare System-Funded Preventive Genomic Screening: Challenges for Australia and Other Single-Payer Systems. Public Health Genomics. 2019; 22(3-4):140-144.
DOI: 10.1159/000502917.
View
16.
McBride C, Bepler G, Lipkus I, Lyna P, Samsa G, Albright J
. Incorporating genetic susceptibility feedback into a smoking cessation program for African-American smokers with low income. Cancer Epidemiol Biomarkers Prev. 2002; 11(6):521-8.
View
17.
Hillyer G, Nazareth M, Lima S, Schmitt K, Reyes A, Fleck E
. E-cigarette Use Among Young Adult Patients: The Opportunity to Intervene on Risky Lifestyle Behaviors to Reduce Cancer Risk. J Community Health. 2021; 47(1):94-100.
PMC: 10034475.
DOI: 10.1007/s10900-021-01027-7.
View
18.
Manchanda R, Patel S, Gordeev V, Antoniou A, Smith S, Lee A
. Cost-effectiveness of Population-Based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 Mutation Testing in Unselected General Population Women. J Natl Cancer Inst. 2018; 110(7):714-725.
DOI: 10.1093/jnci/djx265.
View
19.
Rebbeck T, Burns-White K, Chan A, Emmons K, Freedman M, Hunter D
. Precision Prevention and Early Detection of Cancer: Fundamental Principles. Cancer Discov. 2018; 8(7):803-811.
DOI: 10.1158/2159-8290.CD-17-1415.
View
20.
Buseh A, Kelber S, Millon-Underwood S, Stevens P, Townsend L
. Knowledge, group-based medical mistrust, future expectations, and perceived disadvantages of medical genetic testing: perspectives of Black African immigrants/refugees. Public Health Genomics. 2014; 17(1):33-42.
DOI: 10.1159/000356013.
View